Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 24 June 1994:
Vol. 264. no. 5167, p. 1831
DOI: 10.1126/science.264.5167.1831-a
Prev | Table of Contents | Next

Articles

Corrections and Clarifications

The News & Comment article "Animal tests take back seat to clinical data" by Lisa Seachrist (10 June, p. 1525) misidentified the author of a study that found specific mutations in the tumor-suppressor gene p53 in 50% of liver tumors from rats fed tamoxifen. The work was done by Gary Williams and his colleagues at the American Health Foundation in Valhalla, New York, not by David Kupfer of the Worcester Foundation for Experimental Biology, as the article reported. Kupfer found that tamoxifen is converted to reactive metabolites in the rat liver that become covalently bound to liver proteins; however, it is not known if this is detrimental to the animal.

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)